Mechanisms and prevention of TAVI-related cerebrovascular events

Current Pharmaceutical Design

Volumn 22, Issue 13, 2016, Pages 1879-1887

  Ghanem, Alexander ^a,b   Naderi, Amir S ^a   Frerker, Christian ^a   Nickenig, Georg ^b   Kuck, Karl Heinz ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cerebral injury; Mechanisms; Prevention; Stroke; TAVI; Transcatheter aortic valve implantation

Indexed keywords

ACUTE PROCEDURAL EMBOLIC CEREBRAL INJURY; ACUTE PROCEDURAL NONEMBOLIC CEREBRAL INJURY; ARTICLE; ARTIFICIAL EMBOLIZATION; BRAIN EMBOLISM; BRAIN INJURY; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; HUMAN; INCIDENCE; INTRACRANIAL PRESSURE; PREVALENCE; PRIORITY JOURNAL; SUBACUTE POSTPROCEDURAL EMBOLIC CEREBRAL INJURY; SUBACUTE POSTPROCEDURAL NONEMBOLIC CEREBRAL INJURY; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; HEART CATHETERIZATION; REPERFUSION INJURY;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HUMANS; REPERFUSION INJURY; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84964311486     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151217122610     Document Type: Article

References (72)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43.
2. Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart 2013; 99: 396-400.
3. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142-7.
4. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics -2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245.
5. Ross J, Braunwald E. Aortic stenosis. Circulation 1968; 38: 61-7.
6. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009; 373: 956-66.
7. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111-15.
8. Leon MB, Smith CR, Mack MJ, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607.
9. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-98.
10. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-15.
11. Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 2012; 126: 3041-53.
12. Stortecky S, Windecker S. Stroke: an infrequent but devastating complication in cardiovascular interventions. Circulation 2012; 126: 2921-4.
13. Kahlert P, Al-Rashid F, Plicht B, et al. Incidence, predictors, origin and prevention of early and late neurological events after transcatheter aortic valve implantation (TAVI): a comprehensive review of current data. J Thromb Thrombol 2013; 35: 436-49.
14. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013; 145: 6-23.
15. Kapadia SR, Tuzcu EM, Makkar RR, et al. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation 2014; 130: 1483-92.
16. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2485-91.
17. Tay E, Gurvitch R, Wijesinghe N, et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2011; 4: 1290-7.
18. Eggebrecht H, Schmermund A, Voigtländer T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a metaanalysis of 10, 037 published patients. EuroIntervention 2012; 8: 129-38.
19. Khatri PJ, Webb JG, Rodés-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 2013; 158: 35-46.
20. Di Mario C, Eltchaninoff H, Moat N, et al. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4, 571 patients. EuroIntervention 2013; 8: 1362-71.
21. Linke A, Wenaweser P, Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: The international multi-centre ADVANCE Study. Eur Heart J 2014; 35: 2672-84.
22. Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 371: 967-8.
23. Reardon MJ, Adams DH, Coselli JS, et al. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. J Thorac Cardiovasc Surg 2014; 148: 2869-76.
24. Thyregod HG, Steinbrüchel DA, Ihlemann N, et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Valve Stenosis: One-year Results from the All-comers Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial. J Am Coll Cardiol 2015; 65: 2184-94.
25. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol 2012; 109: 1637-43.
26. Uddin A, Fairbairn TA, Djoukhader IK, et al. Consequence of cerebral embolism after transcatheter aortic valve implantation compared with contemporary surgical aortic valve replacement: effect on health-related quality of life. Circ Cardiovasc Interv 2015; 8: e001913. doi: 10.1161/CIRCINTERVENTIONS.114.001913.
27. Segal AZ, Abernethy WB, Palacios IF, BeLue R, Rordorf G. Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology 2001; 56: 975-7.
28. Hamon M, Baron JC, Viader F, Hamon M. Periprocedural stroke and cardiac catheterization. Circulation 2008; 118: 678-83.
29. Nombela-Franco L, Rodés-Cabau J, DeLarochellière R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv 2012; 5: 499-512.
30. Van Mieghem NM, Schipper ME, Ladich E, et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 2013; 127: 2194-201.
31. Kahlert P, Knipp SC, Schlemann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010; 121: 870-8.
32. Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010; 55: 1427-32.
33. Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011; 57: 18-28.
34. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997; 226: 501-11.
35. Kaireviciute D, Aidietis, A, Lip GYH. Atrial fibrillation following cardiac surgery: clinical features and preventative strategies. Eur Heart J 2009; 30: 410-25.
36. Amat-Santos IJ, Rodés-Cabau J, Urena M, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol 2012; 59: 178-88.
37. Motloch LJ, Reda S, Rottlaender D, et al. Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg 2012; 93: 124-31.
38. Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 2012; 98: 18-23.
39. Selle A, Figulla HR, Ferrari M, et al. Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion. Clin Res Cardiol 2014; 103: 902-11.
40. Stortecky S, Windecker S, Pilgrim T, et al. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention 2012; 8: 62-70.
41. Knipp SC, Kahlert P, Jokisch D, et al. Cognitive function after transapical aortic valve implantation: a single-centre study with 3-month follow-up. Interact Cardiovasc Thorac Surg 2013; 16, 116-22.
42. Ghanem A, Müller A, Sinning JM, et al. Prognostic value of cerebral injury following transfemoral aortic valve implantation. Euro-Intervention 2013; 8, 1296-306.
43. Tully PJ, Roshan P, Rice GD, et al. Change in quality of life after transcatheter aortic valve implantation and aortic valve replacement surgery in Australian patients aged 75 years: the effects of Euro-SCORE and patient operability. J Geriatr Cardiol 2015; 12: 30-6.
44. Bouleti C, Himbert D, Iung B, et al. Long-term outcome after transcatheter aortic valve implantation. Heart 2015; 101: 936-42.
45. Omran H, Schmidt H, Bernhardt P, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 2003; 361, 1241-6.
46. Astarci P, Price J, Glineur D, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg 2011; 40: 475-9.
47. Ringelstein EB, Droste DW, Babikian VL, et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke 1998; 29: 725-9.
48. Kahlert P, Al-Rashid F, Döttger P, et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation 2012; 126: 1245-55.
49. Vermeer SE, Longstreth WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6: 611-9.
50. Knipp SC, Matatko N, Schlamann M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusionweighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg 2005; 28: 88-96.
51. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28: 1956-60.
52. Reinsfelt B, Westerlind A, Ioanes D, et al. Transcranial Doppler microembolic signals and serum marker evidence of brain injury during transcatheter aortic valve implantation. Acta Anaesthesiol Scand 2012; 56: 240-7.
53. Foerch C, Singer OC, Neumann-Haefelin T, et al. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005; 62: 1130-4.
54. Bellomo R, Mårtensson J, Kaukonen KM, et al. Acute renal failure -definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care Med 2015 Epub ahead of print
55. Ussia GP, Scarabelli M, Mulé M, et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2011; 108: 1772-6.
56. Durand E, Blanchard D, Chassaing S, et al. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2014; 113: 355-60.
57. Bagur R, Rodés-Cabau J, Doyle D, et al. Transcatheter aortic valve implantation with ‘no touch’ of the aortic arch for the treatment of severe aortic stenosis associated with complex aortic atherosclerosis. J Card Surg 2010; 25: 501-3.
58. Onsea K, Agostoni P, Samim M, et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 2012; 8: 51-6.
59. Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 2012; 8: 43-50.
60. Nietlispach F, Wijesinghe N, Gurvitch R, et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 2010; 3: 1133-8.
61. Vretzakis G, Georgopoulou S, Stamoulis K, et al. Cerebral oximetry in cardiac anesthesia. J Thorac Dis 2014; 6: S60-9.
62. Paarmann H, Hanke T, Heringlake M, et al. Non-invasive cerebral oxygenation reflects mixed venous oxygen saturation during the varying haemodynamic conditions in patients undergoing transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2012; 14: 268-72.
63. Stabile E, Pucciarelli A, Cota L, et al. SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol 2014; 174: 624-7.
64. Brambatti M, Connolly SJ, Gold MR, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 2014; 129: 2094-9.
65. Brott T, Marler JR, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-70.
66. Lyden PD, Lau GT. A critical appraisal of stroke evaluation and rating scales. Stroke 191; 22: 1345-52.
67. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988; 19: 1497-1500.
68. Walther T, Hamm CW, Schuler G, et al. Peri-operative results and complications in 15, 964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol 2015; 65: 2173-80.
69. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Reg-istry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-9.
70. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
71. Chieffo A, van Mieghem NM, Tchetche D, et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J Am Coll Cardiol 2013; 61: 830-6.
72. Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011; 12: 762-7.